(NaturalHealth365)  On April 25, 2022, the U.S. Food and Drug Administration (FDA) made a shocking announcement about the latest drug they are willing to subject people to – including people as young as 28 days old.

And while Big Pharma company Gilead Sciences touts randomized controlled trials supporting this drug’s safety and efficacy, plenty of real-world evidence suggests that the drug can be downright dangerous and even accelerate death in those who receive it.

Go-to drug used to treat patients hospitalized with COVID-19 associated with severe liver damage – but is apparently perfectly fine to give to infants less than a month old, according to the FDA

In a press release posted to their website last week, the FDA announced that they have “expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, which are:

• Hospitalized, or
• Not hospitalized and have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, including hospitalization or death.”

According to its package insert, remdesivir “is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor indicated for adults and pediatric patients.”  (Veklury’s package insert also says in the notorious “Section 8.1” – which you’ll find in nearly all drug inserts – that “Available data from published case reports and compassionate use of remdesivir in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.”  A little further down in the current insert, it says: “The safety and effectiveness of VEKLURY have not been established in pediatric patients younger than 12 years of age or weighing less than 40 kg.”)

Gilead Sciences, Inc. developed the broad-spectrum antiviral medication in cahoots with Pfizer.  Indeed, Pfizer announced in August 2020 that it secured a “multi-year agreement” to help make and supply the “investigational antiviral” treatment.  Notice that a drug can go from “investigational” (synonymous with “experimental,” according to the FDA) to “approved” by the FDA for INFANTS in fewer than two years’ time.

Meanwhile, we’ve seen countless deaths of hospitalized patients undergoing treatment with remdesivir, and many medical providers actually fear that the drug, NOT the virus, is to blame for these losses of life.

In an interview on The Pete Santilli Show, chiropractor Dr. Bryan Ardis criticizes the widespread use of the toxic drug in American hospitals during the pandemic, saying that Dr. Fauci “knew” that remdesivir “would kill either a quarter to 30 percent of all people he gave the drug to in hospitals in five to 10 days.”

In case you were wondering, these are the known side effects of remdesivir

According to the FDA and the U.S. National Library of Medicine, side effects of remdesivir (which is given intravenously) include the following:

• “Transaminase elevations,” also known as increased levels of liver enzymes – a sign of  severe liver injury (symptoms of which include yellow eyes or skin, dark-colored urine, and pain in the right upper abdomen)
• Allergic reactions, including severe, life-threatening anaphylaxis
• Nausea
• pain, bleeding, bruising, and swelling at the injection site

It is absolutely egregious that “health” officials in this country seriously permit this drug to be given to babies.  The compound has been shown to be extremely dangerous to countless numbers of innocent patients hospitalized while having a COVID-positive diagnosis.

Parents, please know your medical rights, parental rights, and right to informed consent.  Take care of yourself and your loved ones.  Establish a culture of wellness within your family.  Know that you are not “crazy” or “bad” for having questions about what is considered “acceptable” in the conventional healthcare model.

For more information about the dangers of Remdesivir plus much more … listen to this NaturalHealth365 interview with Dr. Bryan Ardis and Jonathan Landsman.

Sources for this article include:

FDA.gov
FDA.gov
FDA.gov
Fiercepharma.com
Pfizer.com
Brighteon.com
Veklury.com
Medlineplus.gov